Concepedia

Publication | Open Access

Twelve-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-related Macular Degeneration

DOIFull Paper Access

492

Citations

17

References

2013

Year

Brandon Busbee, Allen C. Ho, David M. Brown, Jeffrey S. Heier, Iván J. Suñer, Zhengrong Li, Roman G. Rubio, Phillip Lai
Ophthalmology

Abstract

Proprietary or commercial disclosure may be found after the references.

References

YearCitations

Page 1